AI and ML in Drug Development – A Deep Dive at DPHARM
The DPHARM conference brought together a panel of experts to discuss the transformative potential of Artificial Intelligence (AI) and...
The DPHARM conference brought together a panel of experts to discuss the transformative potential of Artificial Intelligence (AI) and...
At Panagora’s 7th Annual Digital Biomarkers in Clinical Trials Summit, Novartis presented a groundbreaking study on digital home-based assessments...
At a recent conference, industry leaders gathered to explore the transformative potential of artificial intelligence (AI) in clinical trials,...
The DPHARM 2024 conference recently convened a panel of industry leaders to discuss the alignment of innovations to address...
The DPHARM conference brought together a distinguished panel to discuss the critical role of technology investment in clinical trials....
At DPHARM 2024, Johnson & Johnson’s representatives, Gordon Gregory III, and Laszlo Vasko, unveiled their transformative “Team of Teams”...
In this interview, Joseph Kim, Chief Strategy Officer at ProofPilot, shares how to revolutionize clinical trials at study sites....
Digital Health Technologies (DHTs) use in clinical research is no longer a futuristic concept—it’s quickly becoming the norm. Recognizing...
In this interview, we speak with Dr. Stephen Deacon, Chief Scientific Officer at Pharmanovia, about the shift towards decentralized...
In a groundbreaking collaboration, Walgreens, AstraZeneca, and digital health company Evinova revealed at DPHARM 2024 that they have embarked on a...